Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Johan Rockberg, PhD
Professor, Antibody Engineering & Directed Evolution at KTH Royal Institute of Technology
Speaker

Profile

Professor in directed evolution and antibody technology at KTH Royal Inst. Technology, Sweden. Director of GeneNova, a center focused on developing platforms for more cost effective, safe and efficacious AAV based gene therapy through interdisciplinary industry and academia collaborations. He is an expert in protein and cell line engineering.

Former co-PI of human protein atlas program cataloging all human proteins. Co-founder five of companies including StrikePharma AB (Uppsala) developing cancer vaccine, Abclon (Seoul, SouthKorea) developing CAR-T and immunotherapy. Elected member of the Royal Academy of Engineering Sciences

Agenda Sessions

  • In Vitro Methods for Selection of Affibodies Using a Combination of Technologies for Generation of Epitope Specific Maturation Libraries

    , 08:20
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Johan at Antibody Engineering & Therapeutics Europe